Melita Sun Jung Terns Pharmaceuticals, Inc. (TERN) insider trading activity

TERN Quotes by TradingView

Melita Sun Jung is Chief Business Officer of Terns Pharmaceuticals, Inc.. Currently has a direct ownership of 2,250 shares of TERN, which is worth approximately $10,417. The most recent transaction as insider was on Nov 30, 2024, when has been sold 2,250 shares (Common Stock) at a price of $5.11 per share, resulting in proceeds of $11,497. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 2.25K
n/a 3M change
n/a 12M change
Total Value Held $10,417

Melita Sun Jung Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 30 2024
BUY
Open market or private purchase
$11,497 $5.11 p/Share
2,250 Added 50.0%
2,250 Common Stock

Also insider at

GPCR
Structure Therapeutics Inc.
Chief Business Officer
MSJ

Melita Sun Jung

Chief Business Officer
South San Francisco, CA

Track Institutional and Insider Activities on TERN

Follow Terns Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TERN shares.

Notify only if

Insider Trading

Get notified when an Terns Pharmaceuticals, Inc. insider buys or sells TERN shares.

Notify only if

News

Receive news related to Terns Pharmaceuticals, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on TERN